Raghd Rostom
InvestorPrincipal at Syncona
About
Raghd Rostom is a Principal at Syncona Investment Management Limited, where she was involved in founding Kesmalea Therapeutics and Yellowstone Biosciences, contributing to their strategic and operational setup. She previously worked in the healthcare practice at Boston Consulting Group, focusing on strategy and digital areas across pharma, biotech and global health. She holds a PhD from the Wellcome Sanger Institute and University of Cambridge spanning computational genomics, cancer and infectious disease.
Invests in
Biotech
Investments
Board seats
iOncturaKesmalea TherapeuticsYellowstone Biosciences
Per the firm's website.
Colleagues at Syncona
Frequently asked questions
- Who is Raghd Rostom?
- Raghd Rostom is a Principal at Syncona Investment Management Limited, where she was involved in founding Kesmalea Therapeutics and Yellowstone Biosciences, contributing to their strategic and operational setup. She previously worked in the healthcare practice at Boston Consulting Group, focusing on strategy and digital areas across pharma, biotech and global health. She holds a PhD from the Wellcome Sanger Institute and University of Cambridge spanning computational genomics, cancer and infectious disease.
- Where does Raghd Rostom work?
- Raghd Rostom is Principal at Syncona.
- What does Raghd Rostom invest in?
- Raghd Rostom invests in Biotech.
- What boards does Raghd Rostom sit on?
- Raghd Rostom holds tracked board seats at iOnctura, Kesmalea Therapeutics, Yellowstone Biosciences.